Patel Sushil

Patel Sushil is listed in filings as Director at Revolution Medicines, Inc.. This profile follows SEC Form 4 activity through Jul 1, 2026, including sale activity. Recent filings connect the profile to Revolution Medicines, Inc. (RVMD) and Replimune Group, Inc. (REPL). The current snapshot covers public activity from May 20, 2026 to Jul 1, 2026. Reported amounts are shown as $169.7K to $114.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.